Reflection paper on a tailored clinical approach in biosimilar development
Reflection paper on a tailored clinical approach in biosimilar development
Reflection paper on a tailored clinical approach in biosimilar development
Human medicines European public assessment report (EPAR): Evista, raloxifene, Date of authorisation: 05/08/1998, Revision: 31, Status: Authorised
RoActemra
IRIS guide to registration and RPIs
Organisation chart: Veterinary Medicines
Minutes of the CAT meeting 19-21 February 2025
SPOR and xEVMPD Stakeholder Engagement Webinars : Substance, product, organisation and referential (SPOR) application programming interface (API) - SPOR API, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 October 2024, 10:00 (CEST) to 14 October 2024, 12:00 (CEST)
SPOR and xEVMPD Stakeholder Engagement Webinars : Referentials Management Service (RMS), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 7 October 2024, 10:00 (CEST) to 7 October 2024, 12:00 (CEST)
SPOR and xEVMPD Stakeholder Engagement Webinars : Product Management Service (XEVMPD) for MAH, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 October 2024, 10:00 (CEST) to 10 October 2024, 12:00 (CEST)
SPOR and xEVMPD Stakeholder Engagement Webinars : Product Management Service (XEVMPD) for Sponsors, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 11 October 2024, 10:00 (CEST) to 11 October 2024, 12:00 (CEST)